摘要
目的:评价贝飞达与山莨菪碱穴封联合治疗小儿迁延性腹泻的临床疗效,为合理应用贝飞达及山莨菪碱治疗小儿迁延性腹泻提供依据。方法:选取60例一个月至2岁的迁延性腹泻患儿为观察对象,把他们随机分为治疗组和常规组。常规组按常规疗法治疗,治疗组在常规疗法基础上口服贝飞达,山莨菪碱足三里穴位封闭;两组均予以补液等对症治疗。两组均进行治疗前后患儿疗效、住院时间及费用的观察。结果:治疗组总有效率明显高于常规组,且住院时间及费用也明显减少。结论:贝飞达联合山莨菪碱穴封治疗小儿迁延性腹泻疗效显著。
Objective :To observe the current situation of bifido and injection anisodamine hydrobromide in point Tsusardi therapy in infant deferred diarrhea. It will give a basis of bifido and injection anisodamine hydrobromide in point Tsusanli on the treatment of infant deferred diarrhea. Methods: 60 infants deferred diarrhea from one month to 2 years old were entered into our observation. They were randomly alloted into two groups: a treatment group and a regular group. The regular group were treated with the regular therapy. The treatment group were also treated with the regular therapy and treated with bifido and injection anisodamine hydrobromide in point Tsusanli. The two groups have been given supplying'Fluid and anty-symptom treatment. Effect of the treatment, the time and the payment in hospital about 60 infants deferred diarrhea were observed. Results: The total effective rate of the treatment group was higher compared with the regular group. And the time and the payment could be reduced in the hospital. Conclusion: it is very effective that Bifido joint Anisodamine Point closure treatment of persistent diarrhea.
出处
《中国医药导刊》
2008年第4期556-557,共2页
Chinese Journal of Medicinal Guide
关键词
小儿迁延性腹泻
双歧三联活菌胶囊
山莨菪碱
Infant deferred diarrhea
Bifid Triple Viable Capsules
Injection anisodamine hydrobromide in point Tsusanli